Skip to main content

1 Result(s)

within A. Vigani Remove this filter Cancer Research Remove this filter Drug Resistance Remove this filter

and

  1. No Access

    Article

    A feasibility study of accelerated polychemotherapy with cisplatin, epidoxorubicin and cyclophosphamide (PEC) in advanced ovarian cancer

    We have evaluated the feasibility of an increase in dose intensity of the cisplatin, epidoxorubicin and cyclophosphamide (PEC) regimen, with granulocyte colony-stimulating factor (G-CSF) support, in 22 patient...

    P Pronzato, G Bertelli, A Vigani, F Vaira in British Journal of Cancer (1996)